Soleus Capital Management, L.P. Essa Pharma Inc. Transaction History

Soleus Capital Management, L.P.

$1.18 Billion
Q3 2024

A detailed history of Soleus Capital Management, L.P. transactions in Essa Pharma Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 4,288,167 shares of EPIX stock, worth $7.72 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares

4,288,167

Previous 4,210,537 1.84%

Holding current value

$7.72 Million

Previous $22.1 Million 17.33%

% of portfolio

2.21%

Previous 2.24%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.45 - $7.1 $345,453 - $551,173	77,630 Added 1.84%	4,288,167 $26 Million
Q2 2024 Aug 14, 2024	BUY	$4.63 - $8.42 $2.88 Million - $5.23 Million	620,979 Added 17.3%	4,210,537 $22.1 Million
Q1 2024 May 15, 2024	SELL	$6.17 - $10.65 $4.55 Million - $7.86 Million	-738,064 Reduced 17.05%	3,589,558 $30.5 Million
Q4 2023 Feb 14, 2024	BUY	$2.74 - $7.35 $111,046 - $297,880	40,528 Added 0.95%	4,327,622 $28.6 Million
Q3 2023 Nov 14, 2023	BUY	$2.65 - $3.31 $225,250 - $281,350	85,000 Added 2.02%	4,287,094 $13.2 Million
Q2 2023 Aug 14, 2023	BUY	$2.6 - $3.34 $148,140 - $190,303	56,977 Added 1.37%	4,202,094 $11.3 Million
Q1 2023 May 15, 2023	BUY	$2.56 - $3.55 $705,856 - $978,823	275,725 Added 7.13%	4,145,117 $12.3 Million
Q4 2022 Feb 14, 2023	BUY	$1.5 - $4.82 $1.84 Million - $5.92 Million	1,228,853 Added 46.54%	3,869,392 $9.75 Million
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.44 $2.67 Million - $5.26 Million	-1,528,260 Reduced 36.66%	2,640,539 $4.81 Million
Q2 2022 Aug 15, 2022	SELL	$3.15 - $7.94 $173,250 - $436,700	-55,000 Reduced 1.3%	4,168,799 $13.1 Million
Q1 2022 May 16, 2022	BUY	$6.18 - $14.44 $4.32 Million - $10.1 Million	698,342 Added 19.81%	4,223,799 $26.1 Million
Q4 2021 Feb 14, 2022	BUY	$7.8 - $14.38 $5.13 Million - $9.45 Million	657,434 Added 22.92%	3,525,457 $50.1 Million
Q3 2021 Nov 15, 2021	BUY	$7.76 - $29.37 $4.89 Million - $18.5 Million	629,919 Added 28.15%	2,868,023 $22.9 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $34.28 $4.06 Million - $5.76 Million	168,052 Added 8.12%	2,238,104 $63.9 Million
Q1 2021 May 17, 2021	SELL	$11.61 - $32.08 $3.55 Million - $9.8 Million	-305,629 Reduced 12.86%	2,070,052 $60.1 Million
Q4 2020 Feb 16, 2021	BUY	$5.47 - $12.1 $3 Million - $6.64 Million	548,701 Added 30.03%	2,375,681 $28.3 Million
Q3 2020 Nov 13, 2020	SELL	$6.0 - $7.79 $1.53 Million - $1.99 Million	-255,205 Reduced 12.26%	1,826,980 $12.6 Million
Q2 2020 Aug 14, 2020	BUY	$3.71 - $6.2 $6,544 - $10,936	1,764 Added 0.08%	2,082,185 $12.9 Million
Q1 2020 May 15, 2020	BUY	$3.23 - $5.87 $1.44 Million - $2.62 Million	446,052 Added 27.29%	2,080,421 $8.32 Million
Q4 2019 Feb 14, 2020	BUY	$3.05 - $6.0 $4.98 Million - $9.81 Million	1,634,369 New	1,634,369 $8.99 Million

Others Institutions Holding EPIX

# of Institutions

Shares Held

35.1M

Call Options Held

15.8K

Put Options Held

21K

View Full List

About ESSA Pharma Inc.

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $79.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

More about EPIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Account

Soleus Capital Management, L.P. Essa Pharma Inc. Transaction History